These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37352230)

  • 1. The structure of a Type III-A CRISPR-Cas effector complex reveals conserved and idiosyncratic contacts to target RNA and crRNA among Type III-A systems.
    Paraan M; Nasef M; Chou-Zheng L; Khweis SA; Schoeffler AJ; Hatoum-Aslan A; Stagg SM; Dunkle JA
    PLoS One; 2023; 18(6):e0287461. PubMed ID: 37352230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Dissection of the Type III-A CRISPR-Cas System Csm Complex Reveals Roles of Individual Subunits.
    Mogila I; Kazlauskiene M; Valinskyte S; Tamulaitiene G; Tamulaitis G; Siksnys V
    Cell Rep; 2019 Mar; 26(10):2753-2765.e4. PubMed ID: 30840895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro assembly of thermostable Csm complex in CRISPR-Cas type III/A system.
    Park KH; An Y; Woo EJ
    Methods Enzymol; 2019; 616():173-189. PubMed ID: 30691642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal Structures of Csm2 and Csm3 in the Type III-A CRISPR-Cas Effector Complex.
    Takeshita D; Sato M; Inanaga H; Numata T
    J Mol Biol; 2019 Feb; 431(4):748-763. PubMed ID: 30639408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coupling of ssRNA cleavage with DNase activity in type III-A CRISPR-Csm revealed by cryo-EM and biochemistry.
    Guo M; Zhang K; Zhu Y; Pintilie GD; Guan X; Li S; Schmid MF; Ma Z; Chiu W; Huang Z
    Cell Res; 2019 Apr; 29(4):305-312. PubMed ID: 30814678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.
    Jia N; Mo CY; Wang C; Eng ET; Marraffini LA; Patel DJ
    Mol Cell; 2019 Jan; 73(2):264-277.e5. PubMed ID: 30503773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular determinants for CRISPR RNA maturation in the Cas10-Csm complex and roles for non-Cas nucleases.
    Walker FC; Chou-Zheng L; Dunkle JA; Hatoum-Aslan A
    Nucleic Acids Res; 2017 Feb; 45(4):2112-2123. PubMed ID: 28204542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic characterization of antiplasmid immunity through a type III-A CRISPR-Cas system.
    Hatoum-Aslan A; Maniv I; Samai P; Marraffini LA
    J Bacteriol; 2014 Jan; 196(2):310-7. PubMed ID: 24187086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural organization of a Type III-A CRISPR effector subcomplex determined by X-ray crystallography and cryo-EM.
    Dorsey BW; Huang L; Mondragón A
    Nucleic Acids Res; 2019 Apr; 47(7):3765-3783. PubMed ID: 30759237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of an active type III-A CRISPR effector complex.
    Smith EM; Ferrell S; Tokars VL; Mondragón A
    Structure; 2022 Aug; 30(8):1109-1128.e6. PubMed ID: 35714601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the Csm3-Csm4 subcomplex in the type III-A CRISPR-Cas interference complex.
    Numata T; Inanaga H; Sato C; Osawa T
    J Mol Biol; 2015 Jan; 427(2):259-73. PubMed ID: 25451598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference Requirements of Type III CRISPR-Cas Systems from Thermus thermophilus.
    Karneyeva K; Kolesnik M; Livenskyi A; Zgoda V; Zubarev V; Trofimova A; Artamonova D; Ispolatov Y; Severinov K
    J Mol Biol; 2024 Mar; 436(6):168448. PubMed ID: 38266982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cyclic oligoadenylate synthesis by the
    Nasef M; Muffly MC; Beckman AB; Rowe SJ; Walker FC; Hatoum-Aslan A; Dunkle JA
    RNA; 2019 Aug; 25(8):948-962. PubMed ID: 31076459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA targeting by the type III-A CRISPR-Cas Csm complex of Thermus thermophilus.
    Staals RH; Zhu Y; Taylor DW; Kornfeld JE; Sharma K; Barendregt A; Koehorst JJ; Vlot M; Neupane N; Varossieau K; Sakamoto K; Suzuki T; Dohmae N; Yokoyama S; Schaap PJ; Urlaub H; Heck AJ; Nogales E; Doudna JA; Shinkai A; van der Oost J
    Mol Cell; 2014 Nov; 56(4):518-30. PubMed ID: 25457165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and Purification of the Cas10-Csm Complex from Staphylococci.
    Chou-Zheng L; Hatoum-Aslan A
    Bio Protoc; 2017 Jun; 7(11):. PubMed ID: 28835904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of Cas10 Govern Discrimination between Self and Non-self in Type III CRISPR-Cas Immunity.
    Wang L; Mo CY; Wasserman MR; Rostøl JT; Marraffini LA; Liu S
    Mol Cell; 2019 Jan; 73(2):278-290.e4. PubMed ID: 30503774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the Csm5 subunit of the type III-A CRISPR-Cas system.
    An Y; Park KH; Lee M; Kim TJ; Woo EJ
    Biochem Biophys Res Commun; 2020 Feb; 523(1):112-116. PubMed ID: 31836139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type-III-A structure of mycobacteria CRISPR-Csm complexes involving atypical crRNAs.
    Zhang H; Shi M; Ma X; Liu M; Wang N; Lu Q; Li Z; Zhao Y; Zhao H; Chen H; Zhang H; Jiang T; Ouyang S; Huo Y; Bi L
    Int J Biol Macromol; 2024 Mar; 260(Pt 2):129331. PubMed ID: 38218299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ribonuclease activity of Csm6 is required for anti-plasmid immunity by Type III-A CRISPR-Cas systems.
    Foster K; Kalter J; Woodside W; Terns RM; Terns MP
    RNA Biol; 2019 Apr; 16(4):449-460. PubMed ID: 29995577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure Studies of the CRISPR-Csm Complex Reveal Mechanism of Co-transcriptional Interference.
    You L; Ma J; Wang J; Artamonova D; Wang M; Liu L; Xiang H; Severinov K; Zhang X; Wang Y
    Cell; 2019 Jan; 176(1-2):239-253.e16. PubMed ID: 30503210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.